Bradley Pharmaceuticals — Merger or Acquisition (December 2007)
16 slides from Bradley Pharmaceuticals's merger presentation, Dec 5, 2007
Slide 1: Integration Planning Team Kick-Off Meeting
Exhibit 99.2 Integration Planning Team Kick-Off Meeting November 27, 2007
Slide 2: Who is Nycomed?
Who is Nycomed? Nycomed Worldwide Headquarters in Zurich Nycomed US Headquarters in Melville, NY Nycomed Worldwide: Nycomed US: Nycomed is a privately owned Nycomed US Inc. (formerly Altana Inc) is a pharmaceutical company that provides subsidiary of Nycomed, which operates medicines for hospitals,
Slide 3: Nycomed US, Inc. – Snapshot
Nycomed US, Inc. – Snapshot A FULLY INTEGRATED US BASED SUBSIDIARY OF NYCOMED History Sales and Sales Operations National Accounts: Retail, Wholesale, Institutional From a small pharmacy in downtown Dermatology Sales Force – 60 sales representatives Brooklyn in 1849, Edmond Fougera of Chaillon, Fran
Slide 4: We have over 158 Years of Experience in the US Pharmaceuticals Market
We have over 158 Years of Experience in the US Pharmaceuticals Market E. Fougera & Co. Service to pharmacy since 1849 From a small pharmacy in downtown Brooklyn in 1849, Edmond Fougera of Chaillon, France, began a business that would survive and thrives to this day. Initially both manufacturing and
Slide 5: We are the leading Manufacturer of Topical Rx Products for the US
We are the leading Manufacturer of Topical Rx Products for the US (made in the USA) Headquarters Production/Labs in Melville, NY Main Production Facility in Hicksville, NY
Slide 6: We distribute over 60 million units (SKUs) each year from our Distribution Centers
We distribute over 60 million units (SKUs) each year from our Distribution Centers Mechanicsburg, PA Tolleson, AZ A 2006 addition of 61,000 square feet brings the New 56,000 square foot DC center opened 2003 total operating area to over 137,000 square feet Equipped with advanced fiber optic Equipped
Slide 7: We are the Leader in Topical Rx Product Research and Development
We are the Leader in Topical Rx Product Research and Development Nycomed US Approvals vs Competitors 14 12 Nycomed 10 Taro 8 Perrigo 6 Total Approvals: 4 Nycomed US – 56 2 Taro – 35 0 Perrigo – 23 2000 2001 2002 2003 2004 2005 2006 Current Product Development Stage Clinical ANDA/ New Product Product
Slide 8: We are the most successful Rx Topical Specialty Manufacturer in the US
We are the most successful Rx Topical Specialty Manufacturer in the US Experts in Topical Product Development: We have successfully developed more topical prescription products for the US market from our labs here in NY than anyone in the world. Experts in low-cost topical Rx product manufacturing:
Slide 9: Our Vision is to leverage this success into a leadership position in Dermatology
Our Vision is to leverage this success into a leadership position in Dermatology Vision Statement Our vision is to become a worldwide leader in the development, manufacturing and commercialization of Dermatology products Strategy Leverage internal core competencies and pursue strategic business deve
Slide 10: Nycomed US Divisions
Nycomed US Divisions Fougera Number 1 supplier of topical Rx and Non-Rx preparations for Net Sales by Division dermatologic and ophthalmic ointment applications 1 Number of Product Groups in 2006: 44 PharmaDerm Number of SKUs in 2006: 267 19% Hospital 23% Hospital/Emergency Medicine Hospital based e
Slide 11: Fougera Division
Fougera Division Fougera Number 1 supplier of topical Rx and Non-Rx preparations for dermatologic and ophthalmic ointment applications 1 Number of Product Groups in 2006: 44 Number of SKUs in 2006: 267 Net Sales (2004-2007) Net Sales ($M) 180 160 140 120 100 80 163 171 157 135 60 40 20 0 2004 2005 2
Slide 12: Hospital/Emergency Medicine Division
Hospital/Emergency Medicine Division Emergency Medicine Hospital based emergency medical products including CroFab (anti-venom), and DigiFab (anti-toxicity) Number of Product Groups in 2006: 4 Number of SKUs in 2006: 7 Net Sales (2004-2007) ($M) 80 70 60 50 40 71 30 63 53 20 44 10 0 2004 2005 2006 2
Slide 13: PharmaDerm Division
PharmaDerm Division Net Sales (2004-2007) Net Sales ($M) 70 2004-2006 60 Net Sales CAGR2 130% 50 117% Gross Profit CAGR2 40 65 30 20 37 10 21 7 0 2004 2005 2006 2007 PharmaDerm Branded dermatological products, including Cutivate, Oxistat, ApexiCon, Temovate, Aclovate, and ClindaMax Number of Product
Slide 14: Nycomed and Bradley - The Perfect Combination of Strengths
Nycomed and Bradley - The Perfect Combination of Strengths Core Strengths Required Capabilities for a Leading Specialty Nycomed Pharmaceutical Company US Bradley Target / Lead Identification Business Development Research & Safety Testing (ADME/Tox, pK studies) Discovery Chemical Analysis and Biostat
Slide 15: Together, we will create the preferred Specialty Pharmaceutical Company
Together, we will create the preferred Specialty Pharmaceutical Company, with a top tier Dermatology Franchise.
Slide 16: Thank you
Thank you Nycomed P.O. Box 2006 60 Baylis Road Melville, NY 11747 T 631-454-6996 F 631-454-1572 www.nycomed.com [email protected]
Bradley Pharmaceuticals — Merger or Acquisition (December 2007) on 6ix